Literature DB >> 20057423

Migration or evasion.

Cornelis Melief.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20057423     DOI： 10.1038/nm0110-35

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

Review 1.  Integration of metabolism and inflammation by lipid-activated nuclear receptors.

Authors:  Steven J Bensinger; Peter Tontonoz
Journal:  Nature       Date:  2008-07-24       Impact factor: 49.962

2.  Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication.

Authors:  Geertje J D van Mierlo; Zita F H M Boonman; Hélène M H Dumortier; Annemieke Th den Boer; Marieke F Fransen; Jan Nouta; Ellen I H van der Voort; Rienk Offringa; René E M Toes; Cornelis J M Melief
Journal:  J Immunol       Date:  2004-12-01       Impact factor: 5.422

Review 3.  Altered macrophage differentiation and immune dysfunction in tumor development.

Authors:  Antonio Sica; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

4.  Locally administered TLR7 agonists drive systemic antitumor immune responses that are enhanced by anti-CD40 immunotherapy.

Authors:  Steve A Broomfield; Robbert G van der Most; Amy C Prosser; Sathish Mahendran; Michael G Tovey; Mark J Smyth; Bruce W S Robinson; Andrew J Currie
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

Review 5.  Taking dendritic cells into medicine.

Authors:  Ralph M Steinman; Jacques Banchereau
Journal:  Nature       Date:  2007-09-27       Impact factor: 49.962

Review 6.  Cancer immunotherapy by dendritic cells.

Authors:  Cornelis J M Melief
Journal:  Immunity       Date:  2008-09-19       Impact factor: 31.745

Review 7.  Immunogenic and tolerogenic cell death.

Authors:  Douglas R Green; Thomas Ferguson; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

8.  Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses.

Authors:  Eduardo J Villablanca; Laura Raccosta; Dan Zhou; Raffaella Fontana; Daniela Maggioni; Aurora Negro; Francesca Sanvito; Maurilio Ponzoni; Barbara Valentinis; Marco Bregni; Alessandro Prinetti; Knut R Steffensen; Sandro Sonnino; Jan-Ake Gustafsson; Claudio Doglioni; Claudio Bordignon; Catia Traversari; Vincenzo Russo
Journal:  Nat Med       Date:  2009-12-27       Impact factor: 53.440

9.  LXR signaling couples sterol metabolism to proliferation in the acquired immune response.

Authors:  Steven J Bensinger; Michelle N Bradley; Sean B Joseph; Noam Zelcer; Edith M Janssen; Mary Ann Hausner; Roger Shih; John S Parks; Peter A Edwards; Beth D Jamieson; Peter Tontonoz
Journal:  Cell       Date:  2008-07-11       Impact factor: 41.582

10.  Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR.

Authors:  Noelia A-Gonzalez; Steven J Bensinger; Cynthia Hong; Susana Beceiro; Michelle N Bradley; Noam Zelcer; Jose Deniz; Cristina Ramirez; Mercedes Díaz; German Gallardo; Carlos Ruiz de Galarreta; Jon Salazar; Felix Lopez; Peter Edwards; John Parks; Miguel Andujar; Peter Tontonoz; Antonio Castrillo
Journal:  Immunity       Date:  2009-07-30       Impact factor: 31.745
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.